Integrated Telemedicine Program Evaluation
ITP
An Integrated, Virtual and On-Demand Solution to Avoid ED Utilization
1 other identifier
interventional
3,200
1 country
1
Brief Summary
This project will evaluate a virtual, on-demand telemedicine program for High emergency department (ED) utilizers with comorbid physical health conditions and behavioral health correlates. Researchers will randomize patients to have either full access to the full intervention (treatment group) or to receive only standard care (control group). Analyses will be intent-to-treat. The primary outcome is the number of ED visits 120 days after the first Best Practice Alert (BPA) firing. The research team plans to enroll 3200 patients in this study. However, randomization may end due to system constraints on December 31, 2025 before reaching that target. This sample provides 80% power to detect a 35% relative reduction in ED utilization using a two-tailed test with an alpha of .15, assuming 40% compliance with the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2025
CompletedStudy Start
First participant enrolled
June 18, 2025
CompletedFirst Posted
Study publicly available on registry
June 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedJune 29, 2025
June 1, 2025
11 months
June 18, 2025
June 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Emergency Department Visits
Number of emergency department visits
within 120 days of the initial BPA firing
Other Outcomes (1)
Health-related quality of life (HRQoL)
Within 120 days of randomization
Study Arms (2)
Integrated Telemedicine Program
EXPERIMENTALPatients will be invited to participate in the integrated telemedicine program through text, email, and/or phone calls.
Control
NO INTERVENTIONPatients will receive only standard care and will receive no invitation to participate in the integrated telemedicine program.
Interventions
The integrated telemedicine program is short-term bridge support provided by a virtually accessible team, including a behavioral health provider (Health Psychologist or Licensed Clinical Social Worker \[LCSW\]) and Community Health Worker (CHW). Once stabilized, members transition from bridge support to ongoing care with a Geisinger Health System Primary Care Provider and Behavioral Health Provider.
Eligibility Criteria
You may qualify if:
- + years old
- + Geisinger ED visits in the last 6 months
- Geisinger Health Plan (GHP) insurance member
- Has a Geisinger PCP
- Patient is being seen at one of the following facilities: Geisinger Lewistown Hospital, Geisinger Medical Center, Geisinger Bloomsburg Hospital, Geisinger Jersey Shore Hospital, Geisinger Community Medical Hospital, Geisinger Wyoming Valley, Geisinger Medical Center Muncy, Geisinger Shamokin Ach Hospital, Geisinger South Wilkes Barre
You may not qualify if:
- Patient being seen in departments determined ineligible by the study team
- Patient is diagnosed with alcohol and substance-related disorders
- Patient is going to receive inpatient care
- Patient is coded in the ED as Level 1 (i.e., seeking life-saving measures)
- Patient has an Intellectual Disability or Traumatic Brain Injury
- Patient is actively seeing a BH provider
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Geisinger Cliniclead
Study Sites (1)
Geisinger Clinic
Danville, Pennsylvania, 17822, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 18, 2025
First Posted
June 29, 2025
Study Start
June 18, 2025
Primary Completion
April 30, 2026
Study Completion
April 30, 2026
Last Updated
June 29, 2025
Record last verified: 2025-06